The global acute care needleless connectors market is expected to register growth over the forecast period. Rising demand for efficient and effective intravenous blood withdrawal and drug administration techniques are expected to boost usage rates of acute care needleless connectors. Furthermore, needleless connector reduces the risk of needlestick injuries to the healthcare practitioners which may give rise to bloodborne diseases. Needleless connectors find their applications in various intravenous medicine administrations and blood withdrawal which is necessary during the treatment course such as acute care hospitals. Since there is a risk of (Catheter-related bloodstream infections) CRBSI, the manufacturers are emphasizing on product design modernization and development of novel connectors, which are capable of minimizing the risk of CRBSI. Complex and simple are the two design types included in the study.
Simple needleless connectors are less expensive and have fewer parts as compared to complex needleless connectors. In addition to this, simple connectors do not have internal mechanical valves whereas complex connectors do have internal mechanical valves that allow nonstraight fluid pathways. Complex connector emerged as one of the highest revenue-generating design types. High availability of complex connectors with mechanical valves is one of the key factors attributing to their large share. However, CRBSI and catheter lumen blockage resulted due to the use of complex connectors and thus the demand for simple connectors is expected to grow at a lucrative rate over the forecast period of six years. On the basis of types of mechanisms the acute needleless connectors market is segmented as a mechanism and dwell time.
Mechanisms are further segmented as negative fluid displacement, positive fluid displacement, and neutral (zero) fluid displacement. Dwell time includes seven-day needleless connectors and other than seven-day connectors. Other than 7 day needleless connectors are expected to grow at lucrative CAGR during the estimated period owing to advantages associated with it such as their cost-effective nature and their added reliability of reduced risk of CRBSI than the 7-day needless connectors. North America, Asia Pacific, Europe, MEA, and Latin America are amongst the key regional markets included in the study. North America emerged as one of the highest revenue-generating region in the global acute care needleless connectors market. Key factors attributing for its large share include rising awareness levels among healthcare practitioners pertaining to the advantages associated with needleless connectors, improved healthcare infrastructure, and rapid growth in the geriatric population.
However, Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as the increasing prevalence of chronic diseases, favorable government initiatives pertaining to the development of healthcare infrastructure, and rapid economic developments in Asian countries such as Japan, China, and India. The key players operating in the global acute care needleless connectors market include Vygon, Ry Med Technologies Inc, Nexus Medical LLC, ICU Medical, Inc., CareFusion Corporation, Becton Dickinson, B. Braun Melsungen AG, and Baxter International Inc.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.